A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study)
Dai Yuhong,Yu Xiongjie,Xu Huiting,et al.A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study)[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(4):doi:10.1200/JCO.2022.40.4_suppl.282.
APA：
Dai, Yuhong,Yu, Xiongjie,Xu, Huiting,Zhuang, Liang,Zhang, Mingsheng...&Yuan, Xianglin.(2022).A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study).JOURNAL OF CLINICAL ONCOLOGY,40,(4)
MLA：
Dai, Yuhong,et al."A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study)".JOURNAL OF CLINICAL ONCOLOGY 40..4(2022)
医学